CVS Health (CVS) PT Raised to $113 at RBC Capital
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $85.94 -1.33%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
RBC Capital analyst Ben Hendrix raised the price target on CVS Health (NYSE: CVS) to $113.00 (from $107.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- UBS Reiterates Buy Rating on CVS Health (CVS) Despite Recent Stock Weakness
- KEPCO (015760:KS) (KEP) PT Lowered to KRW26,000 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
